Oestrogen vs placebo or no treatment
Number with adverse effects ‐ Systemic administration · patients with urinary incontinence in post‐menopausal women
Oestrogen may leads to higher number with adverse effects ‐ Systemic administration compared with placebo or no treatment (low certainty).
1 finding from 1 review
- Oestrogen therapy for urinary incontinence in post‐menopausal women 2012 · Cochrane Headline outcomes onlyRR 13 [1.87, 90.21]1 study · 40 participantsLow